ICG Retention Rate (R15) Test

🟢 ICG Retention Rate (R15) Test: A Complete Guide

One of the most reliable quantitative assessments of liver function


The Indocyanine Green (ICG) Retention Rate at 15 minutes (R15) is one of the most widely used quantitative tests to evaluate hepatic blood flow, hepatocyte function, and biliary excretion capacity.
It is especially crucial in preoperative assessment before liver resection and in evaluating the prognosis of patients with cirrhosis or advanced liver disease.

This guide explains the purpose, test principles, reference ranges, clinical interpretation, and pitfalls—written for clinicians, trainees, and medical professionals.


1. 🧬 What Is Indocyanine Green (ICG)?

Indocyanine Green (ICG) is a non-toxic, water-soluble dye that binds rapidly to plasma proteins (mainly albumin).
Its characteristics:

  • Taken up exclusively by hepatocytes
  • Excreted unchanged into the bile
  • No enterohepatic circulation
  • Not metabolized in the liver
  • Clearance depends on liver blood flow + hepatocyte function

💡 Therefore, ICG retention directly reflects the liver’s capacity to process and clear substances.


2. 🎯 Purpose of the ICG Retention Rate (R15) Test

✔ 1) Quantitative Evaluation of Liver Function

Used to assess the functional reserve in:

  • Chronic hepatitis
  • Cirrhosis
  • Nonalcoholic steatohepatitis (NASH)
  • Alcoholic liver disease
  • Cholestatic disease

✔ 2) Preoperative Risk Assessment for Liver Resection

One of the most important tools for predicting post-hepatectomy liver failure (PHLF).

  • R15 < 10% → Major hepatic resection safe
  • 10–20% → Limited resection recommended
  • > 20% → High risk of postoperative liver failure

Widely used in HCC (hepatocellular carcinoma) surgical planning.


✔ 3) Prognostic and Functional Monitoring

Useful in:

  • Cirrhosis prognosis
  • Acute-on-chronic liver failure (ACLF)
  • Monitoring changes during hospitalization
  • Pre-TIPS evaluation

✔ 4) Outpatient or Inpatient Follow-up

Simple, widely available, and reproducible—suitable for regular assessment of functional decline or improvement.


3. 🔬 Test Method: Colorimetry-Based Measurement

✔ Step-by-step procedure

  1. ICG is injected intravenously at 0.5 mg/kg.
  2. Blood sampling at 15 minutes.
  3. Plasma ICG concentration is measured.
  4. R15 is calculated as:
    (Remaining ICG concentration at 15 min / initial concentration) × 100%

✔ Principle: Absorbance at 805 nm

  • ICG has a characteristic absorption peak in the near-infrared spectrum (~805 nm).
  • The device measures absorbance → absorbance correlates with concentration → yields R15%.

✔ Alternative: Pulse Dye Densitometry (Noninvasive)

Some centers use Pulse Dye Densitometry (PDD):

  • Noninvasive
  • Continuous monitoring
  • Useful in the OR or ICU

4. 📊 Reference Range

ICG R15 (%)Interpretation
< 10%Normal liver function
10–20%Mild to moderate impairment
> 20%Significant dysfunction, high surgical risk

Reference values vary slightly by institution and device.


5. 🩺 Clinical Interpretation (Increase / Decrease)

🔺 When ICG R15 is Increased → Impaired clearance

Seen in:

1) Cirrhosis

  • Reduced hepatocyte mass
  • Portal hypertension
  • Collateral circulation formation

2) Chronic hepatitis / NASH / Fibrosis

Inflammation and fibrosis reduce uptake and excretion.

3) Acute hepatitis

High AST/ALT often accompany impaired ICG clearance.

4) Hepatocellular carcinoma (HCC)

Due to surrounding liver dysfunction + altered perfusion.

5) Drug-induced liver injury (DILI)

6) Reduced hepatic blood flow

  • Heart failure
  • Shock
  • Budd–Chiari syndrome

7) Cholestasis / Biliary obstruction

  • Impaired biliary excretion

🔻 When ICG R15 Decreases

Equivalent to:

  • Normal hepatic perfusion
  • Improved hepatocyte function
  • Recovery from acute injury
  • Clinical improvement after treatment

6. 📚 Diseases Related to Abnormal ICG Values

ConditionMechanismICG R15
Cirrhosis↓ hepatocyte mass + ↓ perfusion
Chronic hepatitisInflammation → ↓ function
NASHSteatosis → fibrosis
Alcoholic liver diseaseToxic injury
Biliary obstructionImpaired excretion
HCCReduced functional reserve
Heart failure↓ hepatic blood flow
ShockPerfusion failure

7. 🩻 Interpretation Pitfalls & Precautions

⚠ 1) Hyperlipidemia

Lipemic plasma may interfere with photometric readings.

⚠ 2) Hyperbilirubinemia

Bilirubin absorbs light in similar wavelength ranges → false elevation of R15 possible.

⚠ 3) Hemodynamic instability

Low blood pressure or heart failure can elevate R15 despite preserved hepatocyte function.

⚠ 4) Strict timing is essential

Sampling errors (not exactly at 15 minutes) directly affect results.

⚠ 5) Drug effects

Any medication that alters bile flow or liver blood flow may affect clearance.


8. 📚 References

  • Paumgartner G. The use of indocyanine green in liver function tests. Gastroenterology.
  • De Gasperi A et al. ICG clearance as a predictor of postoperative liver failure. Ann Surg.
  • Sakka SG. Assessing liver function: ICG plasma disappearance rate. Crit Care.
  • AASLD Practice Guidelines for Liver Disease.
  • Japanese Society of Hepato-Biliary-Pancreatic Surgery: ICG R15 criteria.
  • Benya R et al. Pharmacokinetics of indocyanine green. J Clin Pharmacol.

Similar Posts

  • Arylsulfatase B (ASB) Test

    🧬 Arylsulfatase B (ASB) Test A Complete Clinical Guide for Diagnosing MPS VI (Maroteaux-Lamy Syndrome) 1. What Is Arylsulfatase B (ASB)? Arylsulfatase B (ASB), also known as N-acetylgalactosamine-4-sulfatase, is a lysosomal enzyme responsible for breaking down dermatan sulfate (DS).A deficiency of ASB leads to dermatan sulfate accumulation, which is the hallmark of Mucopolysaccharidosis type VI…

  • 🧪 Pancreatic Amylase Test

    🧪 Pancreatic Amylase Test: Complete Guide Key Enzyme for Acute Pancreatitis · Enzymatic Assay · Reference Range · Clinical Interpretation Pancreatic amylase (P-AMY) is a digestive enzyme responsible for the breakdown of carbohydrates.Amylase exists in two major isoforms: Because P-AMY originates directly from the pancreas, it serves as a highly specific marker for diseases involving…

  • NAG (N-Acetyl-β-D-Glucosaminidase) Test

    🧪 NAG (N-Acetyl-β-D-Glucosaminidase) Test: Complete Review Early Marker of Proximal Tubular Injury · Colorimetric Assay · Reference Range · Clinical Interpretation (NAG test) N-Acetyl-β-D-Glucosaminidase (NAG) is a lysosomal enzyme highly concentrated in the proximal renal tubules.Because it is barely present in blood and is excreted exclusively through urine, urinary NAG levels correlate strongly with the…

  • Arylsulfatase A (ASA) Test

    🧬 Arylsulfatase A (ASA) Test: Complete Clinical Guide for Diagnosing Metachromatic Leukodystrophy (MLD) Arylsulfatase A (ASA) is a lysosomal enzyme responsible for degrading sulfatide.A deficiency in ASA activity leads to pathological accumulation of sulfatide, resulting in Metachromatic Leukodystrophy (MLD)—a progressive demyelinating disorder affecting both the central and peripheral nervous systems. The ARSA gene (22q13) encodes…

  • Cholinesterase (ChE) Test

    🧪 Cholinesterase (ChE) Test: Complete Guide From Liver Function Assessment to Organophosphate Poisoning Diagnosis 1. What Is Cholinesterase? Cholinesterase (ChE) refers to enzymes that break down acetylcholine, a key neurotransmitter. Two major forms exist: 1) Acetylcholinesterase (AChE, True ChE) 2) Pseudocholinesterase (Butyrylcholinesterase, BChE) 2. Purpose of the Cholinesterase Test The test is clinically useful in…

답글 남기기

이메일 주소는 공개되지 않습니다. 필수 필드는 *로 표시됩니다